31 – 40 of 124
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Tumour immune characterisation of primary triple-negative breast cancer using automated image quantification of immunohistochemistry-stained immune cells
- Contribution to journal › Article
-
Mark
The difficulty of studying the association between pathway delays and survival in cancer - an example from bladder cancer
- Contribution to journal › Debate/Note/Editorial
-
Mark
A Versatile and Upgraded Version of the LundTax Classification Algorithm Applied to Independent Cohorts
- Contribution to journal › Article
- 2023
-
Mark
What is a Bladder Cancer Molecular Subtype?
- Contribution to journal › Scientific review
-
Mark
International Opinions on Grading of Urothelial Carcinoma : A Survey Among European Association of Urology and International Society of Urological Pathology Members
- Contribution to journal › Article
-
Mark
Re : Alexander Cox, Niklas Klümper, Johannes Stein, et al. Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.03.020
- Contribution to journal › Letter
-
Mark
FDG-PET/CT for lymph node staging prior to radical cystectomy
- Contribution to journal › Article
-
Mark
Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer
- Contribution to journal › Article
-
Mark
Tumor Biomarkers for Bacillus Calmette-Guérin Response : What We Get Is Not What We Want
- Contribution to journal › Debate/Note/Editorial
-
Mark
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma : 2023 Update
- Contribution to journal › Scientific review
